Aurobindo Pharma Limited — Updates, 05-11-2025: Press Release
05-11-2025 | 08:02 pm
05-11-2025 | 08:02 pm
Aurobindo Pharma reported Q2FY26 revenue up 6.3% to INR 8,286 Cr and Net Profit up 3.8% to INR 848 Cr. Strong growth in Europe (+17.8%) and ARV (+68.7%) drove results. Received 7 product approvals. Net cash stood at USD 170mn.
No comments yet. Be the first to comment!
